Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HKDC1 | Q2TB90 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 7/20 | 0.70 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.70 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.56 |
| ▸ | TYR | P14679 | 1/20 | 0.56 |
| ▸ | GLS2 | Q9UI32 | 3/20 | 0.52 |
| ▸ | TEK | Q02763 | 2/20 | 0.52 |
| ▸ | CDC25A | P30304 | 2/20 | 0.48 |
| ▸ | CDC25B | P30305 | 2/20 | 0.48 |
| ▸ | CDC25C | P30307 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2,6-Dimethoxyquinone SCHEMBL1706801 | 0.86 | KDM4E (0.74) | HKDC1KDM4EMEN1USP2TP53 | |
| SCHEMBL684719 | 0.85 | MAPT (0.73) | HKDC1KDM4EMEN1USP2TP53 | |
| 2,6-Dimethoxyquinone SCHEMBL11304693 | 0.84 | HKDC1 (0.71) | HKDC1KDM4EMEN1USP2TP53 | |
| SCHEMBL21729822 | 0.83 | HKDC1 (0.70) | HKDC1KDM4EMEN1USP2TP53 | |
| SCHEMBL9364524 | 0.83 | MAPT (0.70) | HKDC1KDM4EMEN1USP2TP53 | |
| SCHEMBL7115894 | 0.83 | ALOX5 (1.00) | HKDC1KDM4EMEN1USP2TP53 | |
| SCHEMBL197028 | 0.82 | HKDC1 (0.70) | HKDC1KDM4EMEN1USP2TP53 | |
| Ubiquinone Qo SCHEMBL6760403 | 0.78 | HKDC1 (0.63) | HKDC1KDM4EMEN1USP2TP53 | |
| SCHEMBL10824988 | 0.78 | HKDC1 (0.64) | HKDC1KDM4EMEN1USP2TP53 | |
| SCHEMBL2404062 | 0.78 | HKDC1 (0.61) | HKDC1KDM4EMEN1USP2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 644 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025217103-A1 | DURABLE ION EXCHANGE MEMBRANES WITH ADDITIVES | W. L. GORE & ASSOCIATES, INC. (US) | 2025-10-16 | — | — | WO | claimed |
| US-20250262169-A1 | METHODS OF TREATING COENZYME Q10 DEFICIENCY | THLIVERIS, ANDREW T. | 2025-08-21 | — | — | US | claimed |
| CN-119419302-A | Lithium-fluorocarbon battery electrolyte containing redox medium and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2025-02-11 | — | — | CN | claimed |
| CN-119139480-A | Composition for increasing solubility of quinone compounds and application thereof | 沈阳药科大学 | 2024-12-17 | — | — | CN | claimed |
| WO-2024166382-A1 | PRIMARY BATTERY | 日本電信電話株式会社 | 2024-08-15 | — | — | WO | claimed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | claimed |
| CN-113698039-B | Urine harmless treatment method and system and intelligent toilet based on urine harmless treatment method and system | 中云汇(成都)物联科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-113950520-B | Liquid composition for selective removal of polysilicon relative to p-doped silicon and silicon-germanium during semiconductor device fabrication | 弗萨姆材料美国有限责任公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117491534-A | Method for detecting content of benzoquinone compound in wood | 广电计量检测（重庆）有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-117256396-A | Complex operation method of endangered plant garlic fruits and medicinal plants | 广西壮族自治区林业科学研究院 | 2023-12-22 | — | — | CN | claimed |
| US-20020098979-A1 | Method of controlling zoological and aquatic plant growth | CUTLER STEPHEN J (US) | 2002-07-25 | — | — | US | claimed |
| WO-2001060971-A2 | METHOD OF CONTROLLING ZOOLOGICAL AND AQUATIC PLANT GROWTH | GARNETT, INC. (US) | 2001-08-23 | — | — | WO | claimed |
| EP-0005140-B1 | NOVEL 4-DESOXY-THIAZOLO (5,4-C) RIFAMYCIN DERIVATIVES AND A PROCESS FOR PREPARING THEM | GRUPPO LEPETIT S.P.A. (IT) | 1982-10-27 | — | — | EP | claimed |
| US-4324852-A | REDOX COUPLES | EASTMAN KODAK COMPANY (US) | 1982-04-13 | — | — | US | claimed |
| US-4234485-A | REACTING RIFAMYCIN S, CYSTEINE OR CYSTEAMINE, AN OXIDIZER, AND A HYROXYAMINE, A HYDRAZINE, OR A HYDRAZIDE; ONE-STEP | GRUPPO LEPETIT S.P.A. (IT) | 1980-11-18 | — | — | US | claimed |
| US-4201588-A | NONSILVER PHOTOGRAPHIC FILMS; DISULFIDE, DIAZOANTHRONE, DIAZOPHENANTHRONE, AROMATIC AZIDE, CARBAZIDES OR QUINONES AS PHOTOREDUCTANT; EXTERNAL HYDROGEN SOURCE | EASTMAN KODAK COMPANY (US) | 1980-05-06 | — | — | US | claimed |
| US-4195998-A | NONSILVER PHOTOGRAPHIC FILMS; DISULFIDE, DIAZOANTHRONE, DIAZOPHENANTHRONE, AROMATIC AZIDE, QUINONE OR CARBAZIDE PHOTOREDUCTANT | EASTMAN KODAK COMPANY (US) | 1980-04-01 | — | — | US | claimed |
| EP-0005140-A2 | Novel 4-desoxy-thiazolo (5,4-c) rifamycin derivatives and a process for preparing them | GRUPPO LEPETIT S.P.A. (IT) | 1979-11-14 | — | — | EP | claimed |
| US-4144234-A | Preparation of rifamycin P and Q derivatives | GRUPPO LEPETIT S.P.A. (IT) | 1979-03-13 | — | — | US | claimed |
| US-4129562-A | ANTIBACTERIAL AGENTS WITH LOW TOXICITY | GRUPPO LEPETIT S.P.A. (IT) | 1978-12-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250262169-A1 | METHODS OF TREATING COENZYME Q10 DEFICIENCY | NDUFB10, NDUFA10, NDUFB11 | HKDC1 1832/4885KDM4E 3592/4885MEN1 1538/4885 |
| US-20020098979-A1 | Method of controlling zoological and aquatic plant growth | ANTXR2, NQO2, CYP4A22 | HKDC1 2141/4885KDM4E 2692/4885MEN1 3909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.